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This thesis narrates a prehistory of the Human Genome Project, beginning with the 
intellectual underpinnings of scientific advancement in the middle to late twentieth century. 
Long before official discussions about a microscopic genetic “map” of the human body arose 
within the scientific community in the 1970s, a way array of intellectuals!from the physical and 
medical sciences, as well as philosophers and ethicists!developed a growing interest in this 
seemingly impossible task. Their engagement with the abstract vision of a prospective map 
reveals a complex chronology of debates and discussions that now form a multidimensional 
history of the Human Genome Project (HGP). These histories are intrinsically related to the 
language used to describe and present the body in various scientific contexts. This thesis 
reconstructs a pre-history of the Human Genome Project, with language as a lens for perspective. 
Through this lens, one can trace the transformation of scientific language from a tool for 
intellectual momentum in mapping the molecular body to a pivotal instrument in defining a 
genetic sequence as a patentable product. While narratives about the body can constrain and 
reconfigure our perceptions of self, the outcome of these narratives is never pre-ordained, but is 
instead contingent upon discourses and their power to reconfigure paradigms about the body. In 
a world driven by science, we must reconsider what it means to have a body.  
The Human Genome Project formally began in 1990, when the U.S. Congress jointly 
funded the Department of Energy and the National Institutes of Health to map out the human 
genetic sequence. While the Department of Energy (DOE) was interested in the project as an 
opportunity to study the long-term genetic effects of nuclear radiation, the National Institutes of 
Health (NIH) wanted to maintain its reputation as a leader of American scientific research. As 
Dr. Bernadine Healy, Director of the NIH during the early years of the Human Genome Project, 
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boasted, “the [HGP] is one of the crown jewels of the NIH.”1 With a strong sense of excitement 
from the scientific community, funding was not a concern in early discussions about a 
prospective human gene map.  
The first report issued by the DOE and NIH outlined a fiscal and research-oriented plan 
to complete the project within fifteen years. The fact that the genome was nearly mapped four 
years prior to its intended completion date is indicative of the large-scale intellectual, financial, 
technological, and cultural resources afforded to the Human Genome Project. By 2001, the U.S. 
Department of Energy and the National Institutes of Health has invested approximately 2.7 
billion dollars in the HGP.2 A considerable amount of funding had been allocated to the 
development of new sequencing and database technologies to increase mapping efficiency and to 
reduce the cost of research. Still, scientists were inundated with new information; this resulted in 
questions of storage, access, and ownership of genetic information. All this was dependent on 
having a coherent system of classification for the mapped genomic regions, and a universal 
system of molecular nomenclature.  
Perhaps one of the central challenges for the Human Genome Project- the creation and 
orchestration of its consortium of scientists, laboratories, institutions, and interested parties 
outside of the research community- was also its central accomplishment: the Human Genome 
Project created a dynamic network of collaborations, debates, applications, protests, and 
questions that involved not just scientists, but the community at large. This thesis analyzes the 
contested and complex origins of the HGP and argues that overcoming the challenge of linguistic 
conventions in molecular biology was critical to its development.  
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
1 Veggeberg, Scott. "Watson Departure Vexes Genome Experts." The Scientist Magazine. May 25, 1992. 
2 "2003 Release: International Consortium Completes Human Genome Project." National Human 
Genome Research Institute. April 14, 2003. News Release Archives 
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Therefore, I propose three new perspectives to understand the early history of the human genome 
mapping effort. Each perspective is related to language and systems of terminology in molecular 
genetics. Throughout the thesis, the term ‘nomenclature’ arises in a variety of contexts, both 
historical and contemporary. However, in each instance, nomenclature details a specific turning 
point in the Human Genome Project- from nomenclature’s vital role as a mechanism for the 
HGP’s intellectual momentum, to a precedent set by the cytogenetics community, to the 
actualized legal complications that arose from description of gene sequences in patent 
applications in the 1980s.    
The first section focuses on early descriptions of genetics by public intellectuals. I argue 
that their visions about the possibilities and utilities of a gene map provided the intellectual 
momentum for a seemingly impossible task The second chapter looks at “the nomenclature 
precedent”, that is, how the related field of cytogenetics developed a language classification 
system for DNA protein sequences during the 1960s. This section examines the relative ease 
with which the cytogenetics community developed a terminology system and discusses how 
well-established nomenclature facilitated organization, communication, progressive research, 
and intelligibility in cytogenetics. Finally, the third chapter considers language as a structural 
turning point in the right to ownership of bio-intellectual property. Specifically, the trajectory 
focuses on the Written Description requirement for patent applications and follows how a single 
court case revealed new questions about genetic research and transcended the patent structure in 
place during the 1980s.  
It is my hope that these three perspectives collectively affirm the significance of language 
in configuring twentieth century paradigms of scientific value and standardization. After all, the 
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Human Genome Project is itself a history of the human body as it was constructed, contested, 





Intellectual Momentum: Early Descriptions of a Gene Map 
 
 
“Every map offers only its own perspective on the world, however objective it may appear or 
claim to be, a perspective… implies a particular assertion of reality.”3 –Geoff King 
 
Mapping has long been a physical manifestation of human knowledge: an embodiment of 
the discovery process, an examination of geographic and spatial relationships, a depiction of 
scale and relativity, and a continued effort to understand and explore uncharted landscapes. Yet 
fundamentally, a map is a representation, a medium between reality observed and reality 
rendered. As historian Roy Porter suggests, “to a large degree our sense of our bodies, and what 
happens in and to them, is not first-hand but mediated through maps and expectations derived 
from culture at large.”4 
In much the same way, the following chapters present a relatively recent account of how 
scientists have come to understand and map a fundamental element of the human body: genes. A 
history of the progress and challenges that predetermined mapping the human body is a literal 
taking of the term human geography. In this interpretation, body mapping is based not on the 
relationship of terrain-geography to human movement, but instead upon the ways in which 
intellectual development has demanded a greater understanding of the human body: its functions 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
3 King, Geoff. Mapping Reality: An Exploration of Cultural Cartographies. New York: St. Martin’s 
Press, 1996. 
4 Porter, Roy. Flesh in the Age of Reason. New York: W.W. Norton & Co., 2005. 
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and expressions, its capacities and limitations, and its utilities and possibilities. Even prior to the 
completion of the Human Genome Project in 2003, the gene map had been commended as, “the 
most important, most wondrous map ever produced by humankind.”5 Although the possibility of 
a comprehensive gene map was dazzling, the Human Genome Project was never a pre-ordained 
success. Instead, the project resulted from fifty years of contestation, innovation, and 
determination to map the human body in its most fundamental form.  
A Time of Transition and Possibility  
 The earliest intellectual conundrum of the Human Genome Project presented itself in the 
mid-twentieth century, long before the Project’s official commencement in 1990. The task itself 
was immense; the genome would comprise a comprehensive map of every strain of genetic 
material found in the human body. Billions of microscopic nucleotides had yet to be discovered, 
and the first intellectual issue involved a question of how to map invisible and theoretical 
dimensions of the human body.  
Although the body’s gross anatomy had been mapped centuries earlier, new information 
about the microscopic workings of the body presented unprecedented potential for research, as 
well as practical hurdles. The problem was a matter of discrepancy: although a number of 
scientists predicted a future of research in genetics, a number of practical concerns constrained 
the actualization of genome mapping. During the 1940s, geneticists remained uncertain of the 
structure, function, and location of genes in humans. Scientific instrumentation allowed for 
limited lens visibility and funding for research in the biological sciences had been significantly 
diminished in the wake of war. In 1945, the place of science in post-war America was highly 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
5 Address by President Bill Clinton, The East Room, Washington, DC, June 26, 2000.!
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uncertain.  
Post−War Origins: Vannevar Bush’s Endless Frontier 
“To achieve [our] objectives…the flow of new scientific knowledge must be continuous and 
substantial.”6 – Vannevar Bush 
 
Intellectuals first envisioned gene mapping in the mid- twentieth century, when the end of 
the Second World War marked a time of transition in American scientific communities at large. 
From the development of radar systems to the widespread distribution of penicillin, scientists had 
formed a critical part of the war both at home and abroad.7 Applied physics had advanced 
American war efforts with the introduction of radiation technology, radar capabilities, trajectory 
guided missiles, and hydrophone submarine detection.8 In November of 1944, President Franklin 
D. Roosevelt famously wrote to then−Director of the Office of Scientific Research and 
Development Vannevar Bush to inquire about continued applications of science in a post-war 
society. Bush composed a lengthy response that he entitled Science: The Endless Frontier.9 In 
his manifesto about the future of science in twentieth century America, Bush argued that while 
most wartime scientific research had been applied  (i.e. developed specifically to enhance 
military capacity), a new frontier of knowledge would emerge from universities that encouraged 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
6 Bush, Vannevar. Science--the Endless Frontier: A Report to the President on a Program for Postwar 
Scientific Research. Repr. May 1980. Washington, D.C.: National Science Foundation, 1980. Introduction 
Section 1. 
7 Krige, John and Oreskes, Naomi. Science and Technology in the Global Cold War. Cambridge, 
Massachusetts: The MIT Press, 2014. 11. 




basic research (i.e. research for the benefit of common scientific enterprise).10 Furthermore, Bush 
argued that scientific advancement was the primary indicator of innovation, modernity, high 
standards of living, and a developed nation, which, “…[could] insure health, prosperity, and 
security as a nation in the modern world.”11 This vision marked a turning point in American 
science. During World War Two, applied physics made major contributions to the war effort. 
Whereas physics marked the zenith of scientific achievement in the first half of the twentieth 
century, genetics emerged as a form of basic research, responding to new questions about the 
body that could not be resolved solely with physics research and applications.  
Furthermore, Bush described human disease as a pivotal factor during wartime, and 
suggested that science should support new efforts in understanding disease and infection. He 
noted that “the responsibility for basic research in medicine and the underlying sciences, so 
essential to progress in the war against disease, falls primarily upon the medical schools and 
universities. Yet we find that the traditional sources of support for medical research in the 
medical schools and universities, largely endowment income, foundation grants, and private 
donations, are diminishing and there is no immediate prospect of a change in this trend.”12 Bush 
called for a move to basic research, but he understood that most academic institutions could not 
support the large-scale research he had in mind. His letter to Franklin D. Roosevelt did much to 
sway both political and economic support for the enterprise of biological research. Although 
science was the vehicle of exploration, the human body was the ‘endless frontier’. Following the 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
10 Especially relevant to basic scientific research is a set of norms introduced in 1973 by sociologist 
Robert K. Merton in his work The Sociology of Science: Theoretical and Empirical Investigations. This 
landmark publication outlined ethical principles to guide modern scientific research.  
11 Bush, Vannevar. Science--the Endless Frontier: a Report to the President on a Program for Postwar 
Scientific Research. Repr. May 1980. Washington, D.C.: National Science Foundation, 1980. 
12 Ibid.  
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war, it was the writings of intellectuals from related scientific fields that reified genetics as an 
emergent, yet legitimate, scientific discipline.  
 
A Novel Vision of the Genome 
"The world extended in space and time is but our representation"13 –Erwin Schrodinger  
In 1944, Austrian physicist Erwin Schrodinger delivered a series of lectures at Trinity 
College in Dublin entitled “What is Life? The Physical Aspects of the Living Cell.” In opening, 
Schrodinger asked his colleagues and students, “How can the events in space and time which 
take place within the spatial boundary of a living organism be accounted for by physics and 
chemistry?”14 His question was directed toward minds interested in the study of cellular biology 
and quantum physics, yet his inquiry remained relevant decades after his lecture, when molecular 
biologists asked the same question of human genetics.  
At the turn of the twentieth century the biological science community had rediscovered 
Mendelian inheritance, a finding that sparked further scientific inquiry into genetic inheritance in 
plants.15 However, by the 1940s, the field of human genetics had not yet attained the prestige of 
other biological disciplines. In comparison to fields such as physics, genetics was limited by 
inconsistencies and paradoxes. In 1944, for example, Schrodinger demonstrated that a paradox 
related to the recognition that genetic heredity (by definition) was continuous, and its inherent 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
13 Schrödinger, Erwin. Mind and Matter. University Press, 1958. 22. 
14 Schrödinger, Erwin. "What Is Life? The Physical Aspect of the Living Cell." The American Naturalist, University 
of Chicago Press for The American Society of Naturalists 79, no. 785 (1945): 554. 
15 Many reasons have been offered to explain the rediscovery of Mendel’s work. Although Mendel’s publications on 
hybrid studies were in print during his lifetime, historians have offered several conclusions for the lack of 
recognition Mendel received from his scientific contemporaries. These include: a lack of circulation among his 
contemporaries, continued publication in obscure journals, his status as a monk rather than a scholar associated with 
scientific communities, the fact that his work was not subsequently republished during his lifetime, and Mendel’s 
lack of scientific colleagues and students to continue his work.  
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need to mutate in order to remain stable under changing internal conditions.16 According to 
Schrodinger, this paradox revealed that classical physics could not adequately explain how 
genetic material operated in the human body. The most logical description of human genetic 
structure, he instead suggested, would come from “an elaborate code-script…sufficiently large to 
embody a complicated system of determinations…with an unlimited number of possible 
arrangements.”17 Schrodinger hypothesized that such a code-script could account for the 
possibility of both stability and variability within human chromosomes. The code-script 
Schrodinger described, unbeknownst to him, existed in human chromosomes and served a 
specific function: to transmit and store genetic information.  
 Schrodinger found himself at a midpoint in scientific development: “The first half of our 
century belonged to quantum physics” he affirmed, “but the second half will belong to 
molecular biology and genetics. We have reached a point of dramatic change in our views of 
life and ourselves (and)…great discoveries (are) imminent. The implications (of genetics) will 
change our culture.”18 By “we” Schrodinger meant the biological, chemical, and physical 
scientific communities, that held certain principles that could no longer accommodate new and 
emerging knowledge about the genome. In addition to Schrodinger’s status as a quantum 
physicist, he was also a visionary of scientific prospects because he understood that invisible 
interactions of the quanta informed and even defined visible biological interactions. 
Specifically, Schrodinger noted, “Within every group [of genes] a linear map can be 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
16 Symonds, N. “What Is Life? Schrödinger’s Influence on Biology.” The Quarterly Review of Biology 61, no. 2 
(June 1986): 221–26. 
17 Schrödinger, Erwin. "What Is Life? The Physical Aspect of the Living Cell." The American Naturalist, University 
of Chicago Press for The American Society of Naturalists 79, no. 785 (1945): 554.  
18 Götschl, Johann, ed. Erwin Schrödinger’s World View: The Dynamics of Knowledge and Reality. 
Theory and Decision Library, v. 16. Dordrecht; Boston: Kluwer Academic, 1992. 
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drawn up which accounts quantitatively for the degree of linkages between any two of that 
group, so that there is little doubt that they actually are located, and located along a line, as the 
rod-like shape of the chromosome suggests.”19 He was sure it was possible to construct a linear 
map to organize and catalog the genetic “code-script.” Schrodinger noted that the concept of 
mapping microscopic anatomical space was conceivable because “ the physical interactions 
between our system… must, as a rule, themselves possess a certain degree of physical 
orderliness, that is to say, they too must obey strict physical laws to a certain degree of 
accuracy.”20 Schrodinger’s  recognition of order in the human body created a visible slate to 
examine the internal microscopic landscape. Schrodinger envisioned “linkages” (connections 
between microscopic information) and used their spatial properties to justify his expectation that 
scientists would produce, ‘a sort of map of properties within every chromosome.”21  
However, Schrodinger did not suggest that anatomical “code-scripts” existed in isolation. 
Rather, he believed they formed a “map of properties”22 that accounted for linkages that together 
produced a continuous “pattern of an organism…a whole.”23 The map would have to be a 
compilation of its unitary microscopic structures (i.e. properties of genetic material) and their 
macroscopic counterpart (i.e. the compositional whole, the envisioned genetic map).  He later 
observed that life, in its variety of forms, was, “not merely a piece of this entire existence, but in 
a certain sense the whole; only this whole [was] not so constituted that it [could] be surveyed in 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
19 Schrödinger, Erwin. "What Is Life? The Physical Aspect of the Living Cell." The American Naturalist, 
University of Chicago Press for The American Society of Naturalists 79, no. 785 (1945): 554.  
20 Schrödinger, Erwin. "What Is Life? The Physical Aspect of the Living Cell." The American Naturalist, 
University of Chicago Press for The American Society of Naturalists 79, no. 785 (1945): 554.  




one single glance.”24 Parallel to his parable for life, Schrodinger conceived of ideas that were 
later elemental compilations of the genome project as a structured whole, although he never 
witnessed the human gene map to fruition.  
Nevertheless, Schrodinger’s lectures at Trinity College Dublin represent one of the 
earliest visions of a human gene map, introduced in both an academic and public sphere. 
Delivered first to a public audience, Schrodinger examined a question that would come to deeply 
inform science in the twentieth century: “How can the events in space and time which take place 
within the spatial boundary of a living organism be accounted for by physics and chemistry?” He 
was determined to find a molecular explanation for how the human body operated and changed 
in physical and temporal dimensions. His lecture series ended by affirming that neither the 
events of space nor time could be definitively accounted for by the principles and laws of 
existing scientific disciplines. Aided and limited by the laws of classical physics, Schrodinger 
introduced the possibility of a continuous genetic structure, composed of atomic-sized properties 
and complicated by the paradox of genetic heredity and mutation. Schrodinger’s prediction 
remains one of the earliest visions of a map of the human genome. The writings of Schrodinger 
furthered scientific thought about genetics from an “informational abstraction composed of all of 
the human genes… toward describing the genome as a discrete object.”25 His vision not only 
advanced  intellectual discourses regarding the nature and structure of the gene, it also brought 
the concept of genomic mapping out of the realm of scientific imaginings to that of legitimate 
scientific possibility.  
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
24 Schrödinger, Erwin. My View of the World. University Press, 1964. 28. 
!
25 Hogan, Andrew J. “The ‘Morbid Anatomy’ of the Human Genome: Tracing the Observational and 
Representational Approaches of Postwar Genetics and Biomedicine The William Bynum Prize Essay.” 
Medical History 58, no. 3 (July 2014): 315 
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Mapping the Indeterminate 
Much like early mapmakers of the sixteenth century had overestimated the expansive 
boundaries that defined the world, the scope of the human genome was not accurately predicted 
prior to the charting of its landscape. Estimates regarding the number of genes within the human 
genome varied drastically even beginning in the early 1960s, when German geneticist Friedrich 
Vogel published an estimate that the genome consisted of approximately 6.5 million genes.26 
Vogel derived this number by hypothesizing the weight of amino acids in a particular 
chromosomal chain. His prediction was based on research conducted by Swedish chemist and 
Nobel Prize recipient, Theodor Svedberg. Yet, consistent with Schrodinger’s prediction, Vogel 
under−estimated the size of the genome because he relied on scientific principles that could not 
fully account for the undetermined structure and function of the genome. Indeed, Schrodinger’s 
words echoed from the past. It was not until the outset of the Human Genome Project in 1991, 
that the National Center for Human Genome Research published a report estimating the actual 
number of genes in the genome to be closer to twenty two thousand.27 Despite Schrodinger’s 
vision, the size and scope of genetic material to be surveyed was unclear in the 1960s; this 
resulted in a temporary standstill for the scientific community.  
In 1956, Albert Levan and Joe Hin Tjio successfully identified and published the 46 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
26 Vogel, F. “A Preliminary Estimate of the Number of Human Genes.” Nature 201, no. 4921 (February 
22, 1964): 847–847.  
27 National Center for Human Genome Research (U.S.)|. Understanding Our Genetic Inheritance: the 
U.S. Human Genome Project!: the First Five Years, FY 1991-1995. Bethesda, Md.: National Technical 
Information Service [distributor], 1990. 
For a comprehensive history of efforts to numerate the genome, see: Pertea, Mihaela, and Steven L 
Salzberg. “Between a Chicken and a Grape: Estimating the Number of Human Genes.” Genome Biology 
11.5 (2010): 206.!
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human chromosomal structures from their studies with human lung fibroblasts.28 At the time, 
similar studies in cytogenetics (the study of chromosomes) were halted due to uncertainties in the 
number of human chromosomes (many scientists maintained that the total number was 48, 
identical to the number of chromosomes in the chimpanzee, although scientists later discovered 
that most humans have only 46 chromosomes).29 The findings of Tjio and Levan directly 
contradicted the widely accepted claim that there were 48 human chromosomes. In fact, as 
molecular biologist Stanley M. Gartler points out, Levan had himself published a paper at the 
Sloan Kettering Institute in 1956 (the same year of his collaborative publication with Tjio) that 
affirmed his prediction of 48 human chromosomes.30  
On the one hand, highly regarded geneticists of the early twentieth century, including 
Herman J. Muller and Theophilus Painter, utilized studies of insect and mammalian genes to 
draw conclusions regarding human genetics and their findings remained temporarily 
unscrutinized.31 Yet even respected scientists such as Painter indicated a degree of uncertainty in 
chromosome findings. Painter noted “in my own material the counts range from 45-48 apparent 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
28 Tijo H. and Levan A., ‘The Chromosomes of Man’, Hereditas, 42, 1 (1956) For a detailed account, see: 
Hulten, M. A. "Numbers, Bands and Recombination of Human Chromosomes: Historical Anecdotes from 
a Swedish Student." Cytogenetic and Genome Research 96, no. 1-4 (2002): 14-9. 
29 In their Hereditas publication, Tijo and Levan mention a study of chromosomes in embryonic liver 
mitosis conducted by Dr. Eva Hansen and Yngve Melander, who halted her research because her team 
was only able to locate forty-six of the presumed forty-eight human chromosomes. For further 
information, see: Hartl, Harvard University Daniel L. Essential Genetics: A Genomics Perspective. Jones 
& Bartlett Publishers, 2009. 
30 Levan, A. “Chromosome Studies on Some Human Tumors and Tissues of Normal Origin, Grown in 
Vivo and in Vitro at the Sloan–Kettering Institute.” Cancer 9. 1956. 648–663 
31 For further information on the history of chromosomal discoveries in early cytogenetics, 
please see:  Gartler Stanley M, “The Chromosome Number in Humans: A Brief History” in 
Nature Reviews. Genetics 7, no. 8 (August 2006), 655–660.  
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(human) chromosomes, although the clearest…so far studied only 46 chromosomes have been 
found. There can be no question, however, that the diploid number falls between 45 and 48.”32 
From a methodological perspective, microbiologist Stanley M. Gartler retrospectively 
suggested a number of obstacles that might have prevented numerical confirmation of human 
chromosomes in the 1950s. Certainly, the rarity of accessible human tissue samples prevented 
large-scale quantitative studies. Furthermore, sperm cells, which were especially well suited for 
chromosome counting, were often difficult to obtain. Specimens could also be analyzed only 
within a short timespan before chromosomes merged together and were unable to be separated 
for counting. Finally, Gartler argues that “some investigators believed there might be a natural 
variation in human chromosome number” based on ethnicity.33 The undetermined number of 
human chromosomes created many uncertainties in the human genetic landscape. 
This uncertainty revealed a tendency in early cytogenetic studies to what Malcom J. 
Kottler has termed preconception, the tendency to determine a result based upon previous 
findings that have confirmed its premise 34. Many early studies of chromosomes reported  
48 human chromosomes because investigators who conducted the studies expected to find this 
number. Indeed their work was consistent with (and even based upon) information that was 
regarded as scientifically legitimate at the time. Rather than to affirm uncertainty in the field, the 
work of early cyotgeneticists mistakenly confirmed previously held conceptions that the number 
of human chromosomes totaled 48.  
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
32 Painter, T. S., “The Y-Chromosome in Mammals.” Science 53, no. 1378, (New York, N.Y., May 27, 
1921), 503–504. 
!
33 Gartler, Stanley M. “The Chromosome Number in Humans: A Brief History.” 
Nature Reviews. Genetics 7, no. 8 (August 2006): 655–60.  
34 Kottler, M. J. “From 48 to 46: Cytological Technique, Preconception, and the Counting of Human 
Chromosomes.” Bulletin of the History of Medicine 48, no. 4 (1974): 465–502. 
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  Thus, the discovery of Tjio and Levan did more than substantiate the actual number of 
human chromosomes; it defined a territorial anatomic space with possibilities for further 
investigation, mapping, and clinical utility. The discovery became the foundation of future 
genetic studies, prompted by a new understanding of the chromosome as a structural entity, 
which contained genetic information relevant to disease and family inheritance studies. The very 
process of determining, printing, and distributing the chromosomal structures that contained 
genomic material gave rise to the possibility that the exploration of microbiology might continue 
in both depth and scale; that the internal and once imagined structure of the chromosome might 
yield information to help scientists discern the nature, structure, and functions of genetic material 
contained within each chromosome.  
  In this way, Tjio and Levan’s discovery of 46 chromosomes in human lung fibroblasts 
marked the genesis of cytogenetics (the study of cellular structure and function) as an 
autonomous and respected scientific field. As Victor A. McKusick described “medical genetics, 
which really did not exist as a clinical specialty before 1956, was given its own organ, the 
nucleus…[from which it] evolved into a full-fledged clinical and academic field.”35  Tjio and 
Levan’s momentous discovery yielded this rhetoric about the possibility of mapping genes on 
chromosomes. These figures affirmed, and later challenged a respected hypothesis of their era: 
that humans had fewer chromosomes than related species. Tjio and Levan’s findings allowed 
cytogenetics to have a greater understanding of the microscopic and internal functions of the 
human chromosome. Once the number of chromosomes was accurately known, the boundaries of 
genetic study could be defined both spatially and visually—what Schrodinger had once imagined 
had transformed into visible reality. According to historian Andrew Hogan, Levan and Tjio’s 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
35 McKusick, V. A. “The Anatomy of the Human Genome: A Neo-Vesalian Basis for Medicine in the 
21st Century.” JAMA 286, no. 18 (November 14, 2001): 2289–95. 
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discovery transformed the genome from “an abstract way to identify an individual’s genetic 
material or genes, to referring to an observable and physically bounded anatomical entity”36 that 
could be conceptualized in terms of human chromosomes. With a defined landscape, genetic 
mapping was no longer just a vision, but an actualized possibility. 
Gilbert and the Advancement of Schrodinger’s Vision 
“To recognize that we are determined, in a certain sense, by a finite collection of information 
that is knowable will change our view of ourselves. It is the closing of an intellectual frontier 
with which we will have to come to terms.”37 –Walter Gilbert  
One of the earliest proponents of human genet mapping was Walter Gilbert, a Harvard 
graduate and faculty member, and a pioneer in the field of molecular biology. Like Schrodinger, 
Gilbert had studied physics and chemistry as an undergraduate, and in 1957 he received a 
doctorate in Physics before accepting a tenure-track faculty position at Harvard. As a professor 
of physics, Gilbert learned about the advances in cytogenetics (i.e. the study of chromosomes) 
from collaboration with James D. Watson, co-discoverer of the double helical structure of 
Deoxyribonucleic Acid (DNA). Gilbert notably left his career as a physicist to study molecular 
biology, a relatively novel scientific disciple in the 1960s. Gilbert’s career transition illustrated 
the scientific shift Schrodinger had predicted in the mid-twentieth century; intellectual interests 
refocused toward the science of molecular human anatomy. 
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Gilbert understood that gene mapping embodied a paradox. To Gilbert, the genome 
represented the, “most basic or fundamental information [that]…could be available…”38 and yet 
the task of gathering, storing, and mapping gene sequences was inconceivably colossal. Why 
were the simplest units of scientific information about the body the most difficult to extract and 
to understand? This paradoxical question led Gilbert in search of an answer and a method to 
sequence millions of proteins to understand the functions of DNA.  
In addition to the intellectual challenges associated with mapping the genome, Gilbert 
was also concerned with the structural importance of genetic mapping, including a more nuanced 
view of gene functions. In a well-cited article from Nature, Walter Gilbert suggested that genes 
had an intronic structure, in reference to the intragenic region, the region inside the gene that 
could be spliced in order to be accurately transcribed.39 This structure would allow molecular 
biologists to map proteins and to link strands of genetic material, similar to Schrodinger’s vision 
of linkages. The result of Gilbert’s findings, as he proclaimed in his writing, solved the problem 
of how to accurately duplicate genetic material under certain conditions. The intron model 
suggested that a second carbon copy of specific genetic material was located within the gene. 
Gilbert claimed that “introns are both frozen remnants of history and the sites of future 
evolution.”40 He meant that one copy could be utilized for the study of contextual information 
(i.e. the gene as it normally functioned) and the second copy could be used to examine genetic 
material under changing conditions.41 Gilbert’s model of the intronic gene allowed molecular 
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biologists to understand a unique aspect of the human genome map−genetic expression in 
disparate conditions. One of the greatest challenges of print maps is in inability to account for a 
changing environment. If a natural phenomenon changed the landscape, an entirely new map 
would have to be constructed. Yet, Gilbert understood that a map of human genetics would have 
to be versatile in order to account for a plurality of conditions and expressions in individuals with 
diverse genetic materials. The intronic nature of the gene−its ability to remain preserved in its 
original context and to simultaneously be altered by changing genetic conditions− gave rise to 
the possibility of a versatile genetic map that could accommodate a wide range of expressions  in 
the human genome.   
Although a physical map of the genome served to identify the specific location of 
nucleotides, molecular biologists had not yet mapped the myriad possibilities for expression 
(although a gene may carry sequences for disease, certain environmental and health factors 
determine if and when the gene is expressed in the human body). In other words, scientists would 
be able to map sequences of DNA within the human genome, even though the functions of 
particular genes were not yet known in the 1980s. Furthermore, early methods for physical 
mapping were information-dependent, such that “the mapping of a gene to a specific 
chromosome requires previous knowledge of the location of another gene” further exemplifying 
the importance of locational accuracy in early stage intron mapping.42  
Yet Gilbert remained wary of the vast genomic landscape; he understood that the location 
of a single nucleotide basechange “at the boundaries of the regions to be spliced out, can change 
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the splicing pattern, resulting in the deletion or addition of sequences of amino acids.”43 From a 
geographic perspective, this was a warning against the possible outcomes of faulty mapping 
procedures, where a microscopic change could result in the complete misrepresentation of the 
mapped gene, both in terms of the spatial accuracy (i.e. boundaries) of the region being mapped, 
and in terms of the final product depicting an accurate representation of the base pair sequence. 
His argument highlighted the importance of locational accuracy, because this influenced function 
and the potential for mutations. Additionally, the geographic location of certain base pairs offered 
potential information that would be useful in identifying other sequences. Thus, the spatial 
accuracy of one sequence was not independent from the spatial accuracy of other sequences. 
Gilbert’s concerns over spatial accuracy were later complicated by the drive to map and catalog 
sequences efficiently. Furthermore, Gilbert was not unaware that the genome held significant 
potential for medical and biopharmaceutical applications.44   
As an early proponent of the Human Genome Project, Walter Gilbert firmly grasped both 
the intellectual paradoxes and the technical and regulatory challenges inevitable in the colossal 
project of mapping the human genome. From the intronic structure of genes to the importance of 
locational accuracy in mapping practices, Gilbert’s writings point to specific nuances that were 
central to debates at the outset of the Human Genome Project. Like his predecessors, Gilbert’s 
descriptions of a human gene map contributed the intellectual momentum that contributed to 
both the prospects and complications of a human gene map.  
Morbid Anatomy: A New Application 
“In summary, chromosome analysis, gene mapping, and complete sequencing of the genome 
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provide an anatomic basis for all aspects of clinical medicine.”45 – Victor McKusick 
By the 1980s, much intellectual preparation had been completed to enable sequencing of 
the genome. Tjio and Levan had correctly enumerated and mapped all 46 human chromosomes, 
while Gilbert and many other microbiologists had developed techniques to rapidly sequence 
lengthy strands of DNA. Yet a new frontier was again on the horizon. In 1982, geneticist and 
Professor of Medicine Victor McKusick published an article entitled “The Morbid Anatomy of 
the Genome.”46 His article described the genome as having an anatomy that could be mapped to 
better understand genetics and clinical medicine. In fact, McKusick published a map of each 
chromosome, labeled by section and known function. He proposed that such a map had immense 
utility for clinical medicine, and demonstrated that it was possible to link chromosomal location 
of genes to certain inherited diseases. McKusick’s map earned him a status as the “father of 
medical genetics.” 
McKusick’s method utilized linkage family studies to create an epidemiological map of 
the genome, a physical map of inheritable diseases that could be correlated to certain 
chromosomes. The linkage family studies method utilized genetic information from related 
individuals most often to examine gene-disease associations (i.e. the genetic etiology of disease). 
Familial linkage studies involved an investigation into the likelihood of parent-offspring 
inheritance, chromosomal lineage, studies of gene variation and relatedness of affected family 
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members, and analysis to identify the probability of inheritance or mutation.47 In fact, the first 
gene to have been mapped (in 1911) utilized a Mendelian method to identify the genetic 
characteristics of colorblindness (found by color-dying sex chromosomes) in Drosophila.48 This 
achievement relied on an approach that was a precursor to familial linkage studies, and served as 
a basis for future mapping approaches.  
McKusick had experience with linkage studies prior to his contributions to genetic 
mapping. In 1958, he conducted a population study on inhabitants of Tangier Island on the coast 
of Virginia. Four years later, his interest was redirected to studying hereditary disorders among 
the Pennsylvania Amish.49 This work encapsulated part of the emerging field of population 
genetics, the study of genetic inheritance from a certain subgroup of a population. McKusick’s 
correspondence indicated that the map of chromosomes he published had a number of 
international contributors. In November 1975, Walter F. Bodmer, a population geneticist at 
Oxford, wrote to McKusick to share his findings on chromosome six.50 Given his research 
emphasis and collegial collaborations with population genetics, it is interesting that the map 
McKusick published was not specific to the genetic traits of a particular population, but instead 
catalogued potential disorders from a more normative chromosomal map. Like Schrodinger, 
McKusick was a visionary of the human genome map, and as a product of his era, McKusick had 
the ability and determination to help actualize the genetic map Schrodinger had envisioned three 
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decades earlier. With information on the locations of associated disorders, retrieved from 
colleagues, linkage studies, and population studies, McKusick ensured that the map could 
continuously be updated to accommodate new information.  
From the outset, the map accounted for location (i.e. the site on the chromosome), 
symbols, status (i.e. confirmed, provisional, tentative), title, and what he termed the “MLM 
number.”51  The MLM was an acronym for the Mendelian Inheritance in Man, a compendium of 
identified human genetic disorders. The database included a description of type of disorder, its 
cytogenetic (i.e. chromosomal) location, a list of relationships to other genes, and a clinical 
synopsis to describe traits of physical inheritance. The Mendelian Inheritance in Man Catalogue 
represented an early endeavor to foment access to information about the progress of mapping 
inherited diseases on chromosomes. Prior to his direct work with the morbid anatomy of the 
genome, he understood the possibilities that would result in mapping human chromosomes. In 
1969, McKusick attended a conference on congenital malformations. In his closing address, 
entitled “Birth Defects: Prospects for Progress” he pointed to genetics as the forefront of a new 
scientific frontier, and proposed a, “detailed exploration of the genetic constitution of man.”52 
Like Schrodinger, McKusick was a visionary of future investigation of the human body. As a 
prominent medical scholar at Johns Hopkins, McKusick had the resources and the influence to 
ensure that the utility of the human genome involved clinical applications. Unlike Schrodinger, 
McKusick had the technological resources to pioneer an online inheritance database. From this, 
the body again transcended the processes of physical and spatial mapping; access to information 
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about the body could now be transmitted through machine, and the endless possibilities of the 
endless frontier emerged once again.  
In 1945, Erwin Schrodinger, well renowned as a quantum physicist, gave a speech 
entitled “What is Life?” His inquiry was, in part, a recognition of the changing scientific 
landscape. The laws of quantum physics, which he understood well, could no longer fully 
explain the elaborate genetic code-script that he envisioned nearly four decades prior to the 
Human Genome Project. Fifteen years following his lecture at Trinity College, Schrodinger 
published a short manuscript, which seemed to offer a personal answer to his initial question. He 
wrote that, “The self is not so much linked to its ancestors, it is not so much the product, and 
merely the product, of all that, but rather, in the strictest sense of the word, the same thing as all 
that: the strict, direct continuation of it.”53 This is perhaps how Schrodinger might have viewed 
the Genome Project: that the ideas and descriptions set forth by scholars such as Tjio and Levan, 
Gilbert, McKusick, and countless others were not merely linked to the Project, but instead 





















 The Nomenclature Precedent: Implications of the Denver Conference  
 
“To undertake a history of the sciences…is to show how the establishment of science, and 
perhaps its transition to formalization, have come about in a discursive formation. [Language 
reveals] a whole set of differences, relations, gaps, shifts, independencies, autonomies, and the 
ways in which they articulate their own historicities on one another.”  
-! Michel Foucault54  
 
 Genetics and Language-Based Classification  
Language is a fundamental component of scientific practice. Genetic research methods and the 
interpretation of genetic data is complex enough to constitute a language in itself. Like any 
discipline, the line of intelligibility in genetics is strongly related to language. The language 
scientists use to construct a question informs their answers, just as the ways in which evidence is 
presented influences its reception. In the specific case of genetics, the articulation of problems, 
the methods used to arrive at solutions, and the formation of conclusions depends upon the 
language geneticists use.  
In the 1960s, the sub-field of cytogenetics (the study of chromosomes) prospered 
following the creation of a standardized naming system for chromosome maps. Yet by 1990, at 
the outset of the Human Genome Project, the mapping community had not developed a 
standardized language classification system for gene mapping, a task immensely more 
complicated than chromosome mapping. The result was, as Foucault might have predicted, a 
series of gaps, overlaps, independencies, complications, and duplications in mapping languages 
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and systems. The lack of systematized nomenclature at the outset of the Project reveals much 
about early complications in the Human Genome Project and contributes more broadly to 
debates about scientific standardization and objectivity at the end of the twentieth century.  
 
Early Cytogenetic Mapping Origins and the Denver Conference 
 
By the mid-20th century, the discovery of smaller microscopic gene regions had 
introduced new spaces that contained vast amounts of complex chromosomal information. Such 
information was comprehensible and navigable, in part, because a common system of vocabulary 
existed. This system defined chromosome bands, landmarks, and regions, and held a single 
standard for identifying these areas. Thus, even as the map of chromosomes became increasingly 
complex with the accumulation of more information, the chromosome map remained intelligible 
and useful in facilitating further research.  
Following Joe Hin Tjio and Albert Levan’s landmark confirmation of 46 human 
chromosomes in 1956, the field of cytogenetics began to refine chromosome maps (i.e. 
karyotpyes) for greater visible clarity and resolution. As different mapping methods were tested, 
it became possible to identify distinctions in chromosome forms; cytogeneticists speculated that 
form influenced function.55 If scientists interested in gene location could map the structure of 
chromosomes, the results would reveal information about the purpose and utility of certain 
chromosomes, and a language-based classification system could be used to create maps that 
detailed chromosome form and function. By the 1960s, greater lens resolution led to more 
precise chromosome photographs and cytogeneticists speculated that genes on the chromosome 
might soon be studied in greater detail. If images of the chromosomes were to be translated into a 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
55 To chronologically note these distinctions, please see Figures 1 and 2 (pages 29-30)!
! 29 
map of chromosomes, the information had to be intelligible and navigable.  
According to a retrospective report from the Congressional Standing Committee on 
Human Cytogenetic Nomeclature, “by 1959 several laboratories were engaged in the study of 
human chromosomes and a variety of nomenclature and classification systems ha[d] been 
proposed …this resulted in confusion in the literature and a need to establish a common system 
of nomenclature that would improve communication…in the field.”56 Without a common system 
of vocabulary, cytogeneticists could not determine or reference the sections of chromosomes that 
had previously been studied or mapped. This had the potential to hinder progress on a detailed 
map of human chromosomes.  
In 1960, four years following Tjio and Levan’s discovery, British cytogeneticist Charles 
E. Ford convened a meeting on chromosomal nomenclature in Denver, Colorado. With fourteen 
lead investigators, all of whom had published human karyotypes (i.e. chromosome images), the 
group decided to number the chromosomes and pair corresponding sets together, to demarcate 
the sex chromosomes with “X” or “Y” and to further categorize all chromosomes by size 
groups.57 By the 1960s, cytogenetic studies had been linked to new information about the origins 
of down syndrome and leukemia, and the potential medical applications of these findings created 
exciting prospects for scientists and physicians alike. The nomenclature system developed at the 
Denver Conference remained in use for decades following its establishment, and emerged in 
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response to the need for a common scientific and medical vocabulary to further communication 
and organization in cytogenetics.  
Eighteen years later, the Congressional Standing Committee on Human Cytogenetic 
Nomenclature again stated, “It is fair to say that the participants at Denver did their job so well 
that this report has formed the cornerstone of human cytogenetics since 1960, and the foresight 
and cooperation shown by these investigators prevented much of the nomenclature confusion 
which [now] marks other areas of human genetics.”58 With a clear system of vocabulary and a 
consistent method to identify and categorize new information, cytogenetic research prospered.  
Between 1960 and 1980, cytogenetic research confirmed that chromosome bands 
determined the structure and function of DNA. In a lecture delivered at the National Library of 
Medicine, genome architect Charles R. Cantor stated, “…as we make maps…what we look for in 
these maps are patterns. We hope that there will be some images in the maps which will provide 
clues to function… history, evolution, and organization. And there already is a striking pattern in 
the physical map of the human genome, even seen at this very crude level of resolution, it's these 
bands.”59 Indeed, bands were a crucial part of chromosome mapping; the Congressional Standing 
Committee on Human Cytogenetic Nomenclature identified these bands because the intensity of 
lightness and darkness on the bands was clearly distinguished when the chromosome was 
stained.60 Furthermore, stains indicated particular regions of each chromosome, defined by the 
committee as band landmarks. These landmarks represented greater visible specificity of 
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chromosomal subregions, and cytogeneticists speculated that genes were located within these 
subregions.   
In addition to clear definitions of chromosome band nomenclature, the committee also 
addressed topics of identification and definition of landmarks, the designation process for 
regions and bands, and comments on a diagrammatic representation of these newly discovered 
chromosomal subregions. In fact, the methodology for mapping chromosomes was highly 
intelligible: “In designating a particular band, four items [were] required: (1) the chromosome 
number, (2) the arm symbol (i.e. the short or long arm of the chromosome), (3) the region 
number, and (4) the band number within that region. These items [were] given in order without 
spacing or punctuation. For example, 1p33 indicated chromosome 1, short arm, region 3, band 
3.”61 Cytogenetic chromosome maps became progressively more detailed with higher resolution 
images. Despite their complexity, these maps were intelligible because they followed a single 
system of nomenclature. Initial depictions of chromosomes evolved into regions and bands 
which served as landmarks for genetic diseases. Increased resolution and visibility led to more 
complex mapping spaces, and a set of standardized nomenclature, based on the Denver 
Conference, was utilized to facilitate chromosome mapping as a precursor to gene mapping.  
However, the system developed by the Denver Conference in 1960 also had limitations. 
As historian Susan Lindee points out, the Denver Conference made a critical error when an 
incorrect measurement system misclassified the sizes of chromosomes 21 and 22. In fact, a 
member of the Denver Conference had “misidentified an important chromosome and his error 
was in effect institutionalized, so that the last two human chromosomes ha[d] the ‘wrong’ 
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numbers.” 62 The problem was that the group had identified the location of Down Syndrome on 
the incorrect chromosome and the gene that coded for Down Syndrome was referred to by the 
number 21 based on the Denver classification system, when, as a technicality, gene expression 
for Down Syndrome should have been mapped on Chromosome 22.63 In medical literature 
produced in the decades following this misnomer, the precise location of the chromosome 
remained intentionally misidentified in order to preserve the structure of the nomenclature 
system. Cytogeneticists realized the value of continuity in having  singular, coherent terminology 
to guide research. Despite its imperfections, the Denver naming system remained in place for 
decades following the Denver Conference, and its extensive use by the genetics community 
facilitated communication, organization, and precision in future cytogenetics research.  
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A low-resolution karyotype 
of forty-six human 
chromosomes discovered by 
Tjio and Levan in 1956. 
This image depicts 
chromosomes from a human 
lung fibroblast. From 1956-
1978 cytogeneticists made 
remarkable strides in 
organizing chromosomes so 
that they could be mapped 
and studied in further detail. 
Although not visible at the 
time, high resolution 
photographs made 
chromosome bands later 
visible and created the 
possibility of further 
mapping investigations 
related to genetically 
inherited diseases. Yet 
without a nomenclature 
classification system, 
duplicate sections of the 
genome were still mapped. 
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Figure 2: This image was published by the Standing Committee on Cytogenetic Nomenclature 
that met in Stockholm, Sweden in 1978. It depicts higher-resolution photographs of 
chromosomes 3, 9, and 22 and then-current mapping progress based on the standards developed 
at the Denver Conference in 1960. Note the visible difference in organization in contrast to the 
original 1956 karyotype (as seen above).  
Image reprinted with permission from S. Karger AG, Medical and Scientific Publishers  
 
Nomenclature and the Genome: Early Concerns 
In the 1960s and 1970s cytogenetic research flourished: Francis Crick and Sydney 
Brenner discovered mutations on chromosomes and the function of messenger RNA was found 
to duplicate genetic information on the chromosome.  However, by the 1980s, the system of 
chromosomal nomenclature could not accommodate the continuous discovery of new 
information that operated outside of the pre-existing structure devised at the Denver Conference. 
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The primary problem was one of scale: whereas the map of chromosomes depicted forty-six 
entities, each marked with bands and subregions, the DNA inside of the composite chromosomes 
totaled approximately 3.2 billion base pairs.64  
During the 1960s, rapid and simultaneous advances in genetics facilitated an 
unprecedented amount of data related to genetic sequences, protein synthesis, and gene 
expression. However, technological limitations for dealing with the magnitude of information 
presented yet another problem in the early stages of the Human Genome Project. As Vannevar 
Bush had so aptly anticipated, genetics appeared to be an endless frontier of information. 
Without computer operating systems, it would have likely been impossible to catalogue, archive, 
organize, analyze, and display the information as it was discovered.  
Even so, not all scientists involved in the information-gathering stages of the HGP were 
convinced of the value of mass information collection. An article published in Cytogenetics and 
Cell Genetics noted that, in the early stages of the Human Genome Project, “the increase in 
numbers of newly identified genes [was] not…matched by an increase in functional 
information.”65 Indeed, many believed that the search for information should be localized and 
comprehensive rather than general and expansive. In other words, some proponents advocated 
the collection of a sequence and its functional information so that map entries would comprise all 
available information about the gene studied. However, the approach most common in the 
Human Genome Project was instead the initial collection of as many sequences as possible. This 
presumed that functional information (about disease and inheritance and mutation) would be 
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added to the map after-the-fact. Accordingly, an entirely new nomenclature structure was 
required to accommodate this vast and uncharted genomic landscape.  
Additionally, the nomenclature question was tied to a number of practical concerns about 
the project. Although sponsorship had been discussed by a number of national institutions, 
including the National Institutes of Health, the Department of Energy, and the National Science 
Foundation, the question of responsibility for the establishment and implementation of an 
intelligible language system was unclear. The result was multiple laboratories across the nation 
and the globe conducting research, but using different terms to refer to the same phenomena. 
Such language-based communication barriers hindered the collaborative nature of the endeavor, 
causing some research to be carried out repetitively, while leaving other tasks incomplete or 
unaddressed. More than just an intellectual ideal, the nomenclature issue was reflective of 
broader issues discussed at the outset of the Human Genome Project, including coordination 
between researchers, intelligibility of information, organized and collaborative research, 
institutional purview and implementation of standards to the broader genetics community.  
Approximately one decade before the formal commencement of the Human Genome 
Project in 1990, American proponents of the HGP began to voice their concerns about 
nomenclature.  Dr. Donald Lindberg, the first President of the American Medical Informatics 
Association, advocated for a system of standardized mapping nomenclature in genetics.66 He 
asserted that a system of gene naming, similar to the system of cytogenetic nomenclature that 
had been highly successful in the 1960s, would advance networks of information sharing. The 
kind of coordination that Lindberg envisioned had the potential to standardize gene mapping and 
to allow for greater collaboration in the Human Genome Project. Proponents of a standardized 
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nomenclature system argued that it would significantly reduce the time and resources required to 
complete the human gene map.  
 In 1984, Frank Ruddle, Yale Professor and HGP proponent and architect, argued that, 
“increased knowledge of the gene map makes it easier to map new genes, [as] the techniques 
developed to map one gene are then available to map others.”67  Ruddle believed in the 
significance of standardized mapping nomenclature and its influence on mapping methodology. 
If mapping techniques were not clearly communicated and shared, gene mapping could not 
progress efficiently.68 Concerns over efficiency were likely related to the significant diversion of 
funding toward the genome project, particularly, some scientists felt, at the expense of other 
biological research. The Project was also in its planning stages during the global economic 
recession of the 1970s and 1980s, and efficient research offered the potential for economic 
stimulation in the fields of science, technology, and healthcare.  
Just as cytogenetics had set a precedent for the gene map, genome nomenclature also held 
implications for the future of biology as an academic discipline. In 1982 Dr. Thomas B. Shows, 
the Co-Chair of the Human Genome Nomenclature Committee reported that, “an understanding 
of the human gene map should promote a genetic knowledge of how genes function individually 
and as coordinated sets…such information is essential for defining all aspects of normal and 
abnormal human biology and development.”69 The standards of normalcy set by a system of 
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nomenclature vested significant authority in genetics research. To return to the cytogenetics 
example, the Denver system defined a normal human being as one that possessed forty six 
chromosomes with particular bandwidths and strands. If these bands deviated from the system, it 
was an indicator of mutation and genetic disease. Thus, the power of a system to delineate 
normalcy from abnormality revealed the immense power of a set of nomenclature standards.  
With such power at stake, the Project received scathing criticism from scientists 
concerned with the diversion of funding from other biological research. Between February and 
May of 1990, Michael Syvanen, a professor at the University of California at Davis, organized a 
petition concerning the funding for the Project: “The human genome project is not being funded 
with additional research appropriations; it is being funded with money that would otherwise fund 
the rest of biological research…we are facing an unprecedented crisis in American biological 
research funding.”70 This funding crisis was in part a result of potential sponsorship for the 
Project as sponsorship contenders were the National Institutes of Health, the Department of 
Energy, and the National Science Foundation: the three primary sponsors of American scientific 
research. Although a system of standards emerged early on in other areas of genetic research, 
these standards did not reach the Human Genome Project until the 1970s.  
Even after the formal commencement of the Human Genome Project in 1990, a standard 
system for genome vocabulary was still being discussed in academic circles and among potential 
institutional sponsors. The lack of a formally implemented nomenclature system created 
problems even in the first year of the HGP.  In a letter to Dr. Elkye Jordan, then director of the 
National Center for Human Genome Research, Dr. Kenneth Kidd of Yale noted that, “the criteria 
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used to select (genome) markers were different” for each mapping committee and that the HGP 
would require a coordinated effort to, “avoid presenting information in seemingly conflicting 
ways that might confuse others and retard effort toward…a complete and accurate genetic 
map.”71 By 1990, the first year of the Genome Project, no single or standardized system for 
genome mapping nomenclature had been agreed upon or implemented. Yet the problem was 
recognized within the mapping community. In a meeting held the same year, the Human Gene 
Mapping Workshop Executive Committee met at Saint John’s College, Oxford, to discuss the 
future of mapping meetings. Nomenclature was the first item listed in the meeting minutes. Due 
to the size of previous mapping workshops (specifically, the number of attendees and the amount 
of new material generated), the committee felt that an established system of nomenclature would 
allow standardization across subcommittees, many of which could not attend each individual 
mapping workshop.72  By the introductory year of the Human Genome Project, nomenclature 
debates influenced the structure and coordination of mapping workshops and meetings.  
 Nomeclature also revealed the technical difficulties of mapping genetic information with 
an unknown structure. Whereas function was generally known prior to the mapping of 
chromosomes, and the naming system was based on size and function, it was nearly impossible 
to map structures that were still being discovered within the genome.  Thus, naming standards 
could not incorporate protein function into a genetic nomenclature system. This problem 
highlights an early criticism of the Project itself, that protein coding occurs in approximately 2% 
of the genome, while the remainder of the genome embodies non-coding (i.e. “junk”) DNA. 
Early critics of the Project posed a cost-benefit analysis that proved that 98% of information 
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from the fully coded genome was not readily applicable to the Human Genome Project. Instead 
of mapping the 2% coding segment of the genome, researchers elected to map the sequences in 
their entirety, including the 98% of noncoding genes with no known biological function.  
 
Unanticipated Consequences: Duplication and Pathology  
 
Without a standardized system of nomenclature, discussions of the genome were difficult 
for both the scientific community and the public. In the absence of a common vocabulary, 
communication between institutions that collaborated on the Human Gene Project remained 
muddled. Without a common organizational system to classify, document, and exchange 
information about the progress of gene mapping, project architects had no clear method to 
exchange standardized information about mapping progress.  
An article published in the midst of the project highlighted the problems of duplicated 
segments ingrained in the gene map. The Segmental Duplication research group found that 3.6% 
of the entire map was composed of duplicate segments. The report stated that these sections of 
the map were “over-represented in unordered and unassigned contigs (that is, overlapping DNA 
segments) indicating that duplicated sequences [were] difficult to assign to their proper 
positions.”73 Studies had already confirmed the significant pathological and disease related 
consequences of duplicated segments. These mapped duplicates resulted in “new functional roles 
in the organism” and “local deletions, duplications, and inversions” of gene sequences.74 Human 
cognitive and physical problems associated with genome sequence duplication included: color 
blindness, Emery-Dreifuss muscular dystrophy, Hunter Syndrome, Hemophilia, and spinal 
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muscular atrophy.  Furthermore, pathological mutations were attributed to the, “mapping of the 
region in the vicinity of the breakpoints with…markers [that] show[ed] that some sequences are 
repeated in the areas that border the deletions.” Specifically, mapping data on Xq28 (i.e. the X 
chromosome, long arm, band 2, region 8) indicated that an estimated 10% of this sequence [was] 
duplicated at least once.75 Yet the severe consequences of sequence duplication were not 
considered in reports published by the genome nomenclature committee. Without an 
organizational system to classify, document, and exchange information about the progress of 
gene mapping, researcher had no clear method to exchange standardized information about 
mapping progress.  
In addition to concerns over standardization, and unlike the intelligible system outlined 
by cytogeneticists at the Denver Conference in 1960, genetic mapping language was highly 
inaccessible at the outset of the Human Genome Project in 1991. Genome contributors held 
varying degrees of scientific literacy and education, and there existed no shared system of 
vocabulary for the exchange of information. Thus, the majority of knowledge generated by the 
Project was incomprehensible to a non-specialist public:  
As part of the pattern, for example, restriction mapping of the short arm of chromosome 
16 has revealed that three different alleles of the α-globin gene lie, respectively, 170, 350, 
and 430 kb from the telomere (Wilkie et al. 1991). Polymorphic length variation at this 
locus is postulated to have arisen by nonhomologous exchanges between the 
subtelomeric repeats on different chromosomes. Furthermore, heterozygosity for the 
telomere polymorphism may have an effect on meiotic segregation. Because most 




chromosome 16 may be more frequent in heterozygotes for the subtelomeric region 
(Speed 1988). Interestingly, trisomy of chromosome 16 is the most common trisomy seen 
in early natural abortuses.76 
This example illustrates that information produced about genetic mapping influenced 
communication standards, information-sharing, and intelligibility. The absence of a standardized 
system of nomenclature affected mapping efficiency, as non-named sections of the Genome were 
duplicated. This error not only produced inaccurate sections of the gene map, but directly 
affected the study and correct diagnosis of genetically-inherited diseases outlined in the map. 
Still, genetic nomenclature varied by laboratory, by region, and by working research groups. 
Similar to colloquial language variations, mapping language in the Human Genome Project was 
not formalized. Instead, several systems for identifying, classifying, and reporting new genetic 
research existed simultaneously. Certain research groups relied upon numeric classification 
systems, while other groups classified their findings based on size, estimated function, or 
geographic location on the physical gene map. The absence of a singular standardized 
nomenclature system highlights the Project as a cultural and social endeavor, subject to 
variations and inconsistencies. While nomenclature directly shaped the possibilities and 
limitations of the Human Genome Project to its completion, the genetic vocabularies that 
emerged in the twentieth century have now, “create[d] situations that transcend our legal 
structure and directly affect our social and moral fabrics. Thus there is a great need to continue 
dialogues between the judiciary, the legal community, the legislature, the interested public, and 
the scientific community to provide guidance in scientific developments that hold major impacts 
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for society.”77 Nomenclature is but a single example that reconfigures the Human Genome 
Project as a cultural and social project, defined and actualized by the language systems that 
enabled the creation of a long-envisioned human gene map.  
 
Nomenclature and Standardization: 
 
Throughout the early to mid-twentieth century, scientists envisioned the mapping of the 
human genome in different ways and the absence of a common vocabulary hindered the Project’s 
actualization. By the 1980s, many technological and scientific advances made the Human 
Genome Project feasible, and a number of renowned scientists and physicians, including Walter 
Gilbert and Victor McKusick, were involved in planning the mapping and sequencing effort.78 
Architects of the Project were also responsible for anticipating the large-scale organizational and 
structural complexities associated with the Human Genome Project. Other potential concerns 
included funding sources, collaborative efforts between public and private institutions, 
information-sharing, and the need for a committee to address ethical, legal, and social 
implications of the project. These concerns have largely been explored in a number of secondary 
historical writings and reveal intellectual debates that were addressed at the outset of the 
Project.79 However, the issue of standardized genome nomenclature was not adequately 
anticipated in the wake of ethical and social concerns about mapping the genome.  
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Central to the nomenclature debate was the question of standardization. The mapping 
process, reliant upon descriptions of genes and their relative locations on chromosomes, might 
have been significantly simplified by a standardized scientific language to describe, reference, 
catalog, transfer, map, and share information about the genome. In a letter written the 
commencement year of the Human Genome Project Dr. Phyllis McAlpine noted her “concerns 
about the release of developing maps…while [she did] not disagree in principle, with the rapid 
release of scientific information [she held] deep reservations about the process as no 
consideration appear[ed] to have been given to standardized nomenclature. [She] believe[d] that 
a major contributing factor to the authoritative nature and universal comprehension of the maps 
developed at the Human Genome Mapping workshops [could be] the insistence on standardized 
nomenclature so that all mapping information [could] be captured readily in the electronic 
databases of information pertaining to the map of the human genome.”80 McAlpine later served 
as the chair of the Human Genome Nomenclature Committee, an international organization that 
advocated the necessity of standardized terminology for an endeavor as collaborative and as 
colossal as the mapping of the human genome. Established formally in 1979, the Human 
Genome Nomenclature Committee signaled an institutional acknowledgement that an established 
terminology was critical to the HGP’s organization and progress. Her perspective concerned both 
the logistical importance of standardized nomenclature for information-sharing and the 
“authoritative nature” that a singular terminology would produce.81 The authority of standardized 
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nomenclature had the potential to lend the genome project credibility (from consensus within the 
mapping community) and accessibility (to sequenced portions of the genome map). The 
completed map introduced opportunities for burgeoning biomedical and pharmaceutical 
economies, highly advanced medical research, the generation of new knowledge about human 
disease, and the academic prestige of mapping the human genome. 
Even so, the human genome project relied upon, and even valued, processes of 
standardization to further ground the effort as objective and scientific. The methods used to 
establish this system of nomenclature were developed in the midst of the Project and cannot be 
separated from their historical setting. The work of M. Norton Wise provides a useful framework 
for understanding how precision and standardization of genome nomenclature reveals a matrix of 
discursive power, scientific values, and the subjectivity of human cartography.  
 In his work, The Values of Precision historian M. Norton Wise argues that precision and 
standardization in science are inseparable from cultural and historical values. He describes 
precision as a modern value that has a history closely related to scientific development. Wise is 
not the first historian to suggest that the scientific value of precision, far from ubiquitous and 
ahistorical, is a product of Enlightenment thought.82 Wise defines precision as, “responsible, 
nonemotional, objective, and scientific.”83 He writes that precision requires reliability and must 
be agreed upon within a community. Precision, “requires an extensive set of agreements about 
materials…methods, and values that reach out into the larger culture.”84 In order to form these 
agreements, and to arrive at a standard, a consensus much be reached from a network of 
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individuals. Precision, therefore, relies on a set of standards agreed upon by a community; this 
yields standardization. Ultimately, Wise argues that the process of standardization creates 
reliability, credibility, and makes numbers transportable beyond culture, and therefore valuable 
to a community concerned with precision and objectivity. As a historian of science, Wise’s 
framework of precision and standardization is highly applicable to the Human Genome Project. 
There is utility in examining the debate about nomenclature in the Human Genome Project as a 
contribution to the contested history of standardization in modern science.   
It is noteworthy that the mapping of the genome is only a recent example of how cultural 
and social values are reflected in scientific systems of classification and nomenclature. The 
classification system developed at the turn of the twentieth century to categorize ABO blood 
groups among individual populations remains a classic precedent of social values that influenced 
microbiological research. As authors Gannett and Griesmer describe, “‘racial’ classifications 
based on the physical characteristics of humans were subject not only to observations of the 
appearance of variation and difference, but also to judgments of categorical difference and to 
ethnic, cultural, and national biases that served as a priori classifications guiding sampling 
protocols for research on biological traits.”85 This is not dissimilar from mid-twentieth century 
speculations that human chromosome numbers were dependent upon race or ethnicity.86  
The lack of systematized nomenclature at the outset complicated the development of the 
Human Genome Project and contributed more broadly to debates about scientific standardization 
and objectivity at the end of the twentieth century. Thus, even as the map of chromosomes 
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became increasingly complex with the accumulation of more information, the chromosome map 
remained intelligible and useful in facilitating further research. Indeed, the importance of clear 
and structured mapping nomenclature was highly relevant to the map’s continuity and progress. 
Without a common organizational system to classify, document, and exchange information about 
the progress of gene mapping, project architects had no clear method to exchange standardized 
information about mapping progress. Even so, the human genome project relied upon, and even 
valued, processes of standardization to further ground the effort as objective and scientific. As 
historians have accounted for racial, social, and political biases that influenced classifications for 
blood groups, historians now have the responsibility to account for cultural and social biases that 































Written Description: A Reconfiguration of Intellectual Property  
 
“By the first decades of the twentieth century, the range of standard-setting institutions in many 
respects resembled our [current] situation…a decentralized and pluralistic constellation of 
institutions, each pursuing standardization to suit their own objectives within a dynamic and 
competitive context.”87 – Andrew L. Russell 
 
1960 marked the beginning of a decade defined by advancements in the field of genetics. 
A number of discoveries in microbiology further expanded opportunities for new research about 
the structure, function, and utilities of Deoxyribonucleic Acid (DNA). In 1960, just three years 
after Watson and Crick discovered the binary helical structure of DNA, Sydney Brenner, Francis 
Crick, François Jacob, and Jacques Monod solved a problem that had eluded geneticists for 
nearly a decade. Their research team, sponsored by the California Institute of Technology, had 
discovered Messenger Ribosomalnucleaic Acid (mRNA), a set of molecules that were 
responsible for transferring genetic information to the cytoplasm, where genetic information is 
expressed.88 The next year, thirty-four-year-old Marshall Nirenberg uncovered that the genetic 
code was comprised of chemical units of DNA that specify how protein molecules are 
constructed. By 1966, Dr. Nirenberg had identified the first sixty-three sequences of DNA.89 
Two years later, in 1968, Nirenberg and his colleagues were awarded the Nobel Prize in 
Physiology and Medicine for, “their interpretation of the genetic code and its function in protein 
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synthesis.”90 The discoveries from the 1960s carried unprecedented individual import in the 
genetics community, but also collectively prompted new opportunities for discovering and 
assembling a map of the human genome. As individual research groups, laboratories, 
universities, and private institutions independently sponsored continued genome research, the 
issues of intelligibility and nomenclature norms remained unresolved.  
Yet during this era of continuous discovery, no singular guidelines were in place to 
ensure that the information was uniformly treated. Several repositories existed to store newly 
collected information, although no nomenclature system existed to describe the 
location/structure/function of discovered genes. Certainly the need for a standardized system of 
nomenclature was discussed, and even advocated for in the midst of the Project. Its absence in 
the early planning stages of the Human Genome Project prompted several legal battles that 
transcended the existing legal framework for intellectual property in the life sciences.  
By 1960, the field of cytogenetics had set a strong precedent for developing a 
standardized nomenclature system to facilitate and organize new information related to human 
chromosomes. The naming system developed in Denver was descriptive and intelligible to the 
extent that a lay person could locate a particular chromosome band and then retrieve hereditary 
information from their search. Despite its lauded success in the cytogenetics community, a 
nomenclature system was not established in the early stages of the Human Genome Project. 
However, the possibility of such a system was discussed several years prior to the formal 
commencement of the Human Genome Project. Indeed, the debate was not whether a system of 
nomenclature should be developed and utilized as an organizational tool, but how the system 
should be developed and implemented. Certainly it would seem that no single laboratory should 
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have the authority or responsibility to establish such a system, but rather a prominent 
institutional sponsor.  
 On December 29, 1965 the National Institutes of Health received a manuscript from a 
team of geneticists working at Cold Spring Harbor Laboratories in Long Island. The seventy-six-
page report was titled, “A Proposal for Uniform Nomenclature in Bacterial Genetics.”91 The 
proposal was developed from a paper published in 1953 at Brookhaven National Laboratory and 
sponsored by the U.S. Atomic Energy Commission that suggested a basic system for naming, 
referencing, and cataloguing genetic information.92 The paper defended the importance of a 
nomenclature system from a number of perspectives; it suggested that such a system was 
convenient and pragmatic (since individual research groups would not need to devise their own 
classification system), that it facilitated understanding and communication in the field, and it was 
malleable enough to accept new genetic information. The authors, a team of international 
geneticists, affirmed that: 
“the aims of the present proposal are: uniformity, a unique designation for each strain, 
convenience for typing, editing, printing, record-keeping, and information retrieval; and 
adaptability, simplicity, and clarity, and comprehension by workers in all areas of 
biology; adaptability to new developments in the foreseeable future.”93  
 
The report concluded with an example of the system implemented; it contains a list of 
proposed standard symbols, based on known gene function. The report also included several 
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recommendations for implementation. However, nine years passed before the nomenclature 
question was again discussed in mapping meetings.  
 Held in Rotterdam, the 1974 Human Gene Mapping Conference was the first formally 
recognized and collective call for a nomenclature system. Although no formal guidelines were 
established, a committee was formed to discuss the possibility of standardized terminology. The 
advantages were clear: increased organization in mapping, intelligibility and access to 
information, and a decreased likelihood that researchers in different labs would replicate research 
under various descriptions. The committee consisted of: Dr. Harry Harris from the University of 
Pennsylvania School of Medicine, Dr. Meera Khan of the Netherlands Department of Human 
Genetics, Tom Shows microbiologist and editor of Cytogenetics and Cell Genetics, and Dr. 
Victor McKusick of Johns Hopkins School of Medicine. Deemed the Committee on 
Terminology, the group determined that, “…guidelines need[ed] to be established for naming the 
human genetic markers, including the terms to be used for loci, genes, phenotypes, and 
polypeptide chains To provide time for the review, as well as subsequent discussion and 
appropriate review of existing terminologies, the members decided that a separate meeting of the 
committee would be required.”94 
The committee met again the following year to discuss further the possibility of a 
nomenclature system, although one was not presented until the Human Gene Mapping 
Conference in Edinburgh in 1979. In the five years that had passed, two events had already 
shaped the future prospects of the Human Genome Project, and had revealed both the potentiality 
and the complexity of mapping without a single system of nomenclature.  
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After-the-Fact: NIH Standards and the Cambridge Gene Scare  
 1977 was a critical year in advancing the prospects of a Human Genome Project. The 
June before, researchers at Harvard and Massachusetts Institute of Technology had developed a 
technique known as gene splicing. The process allowed researchers to manually insert sections of 
foreign genetic material into pre-existing genetic material. Splicing was also used to create new 
genetic sequences. Combined with recombinant DNA techniques, gene splicing theoretically 
allowed geneticists to insert a gene sequence into a pre-existing sequence and then replicate this 
new segment widely. One of the earliest applications of gene splicing technology was a method 
to replicate human insulin.   
 By 1977, gene splicing caused a sensational controversy in both the media and scientific 
circles. The New York Times reported that, “the primary fear of the area’s residents is that new, 
particularly durable viruses could escape from a laboratory...attention was [also] focused on 
commercial concerns, which are not subject to the Government regulations that control gene-
splicing research at federally financed universities or hospitals.”95 In response to what later 
became known as the “Cambridge Gene Scare” the Cambridge Public Health Department and 
Cambridge Town Council issued a set of ordinances regulating activities related to gene splicing. 
In the months prior to this regulation, the Town Council had issued a moratorium on gene 
splicing research within the city.96 The February 1977 issue of Science outlined the various local 
protocols developed in response to growing concerns over gene splicing technology. In a matter 
of months, Massachusetts, New York, California, Michigan, New Jersey, and Wisconsin had 
each issued protocol for gene splicing practices in regional laboratories.  
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“Having held public hearings on the gene splicing technique, the state attorney general’s 
environmental health bureau has prepared a bill to control the research. The bill…would 
require everyone engaged in gene-splicing research or production to obtain a certificate 
from the state health commissioner, who would also specify training… [and monitor] 
containment facilities.”97 
Just one month earlier, in January of 1977, the National Institutes of Health had revised 
their guidelines for recombinant DNA research.98 The updated guidelines, later given federal 
authority as legislation, included regulations on genetic splicing and replication.99 Public fear 
was not only related to the health and safety of communities where gene splicing research 
occurred, but also to its potency as a weapon of biological warfare.100 After an outbreak of public 
dissatisfaction, the National Institutes of Health (NIH) authorized national standards for gene 
splicing.  
 The gene splicing ordinances issued by the NIH involved the consolidation of many local 
practices for gene splicing. The Cambridge Gene Scare also roused the attention of several 
national organizations, including the Occupational Safety and Health Administration, the 
Environmental Protection Agency, and the Food and Drug Administration. The creation of a 
single standardized system yielded uniform guidelines about gene splicing safety occurred only 
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after public outrage prompted changes in regulation. However, in addition to the consolidation of 
local regulatory practices, each federal department also issued independent regulations. As 
historian Andrew Russell described in the context of national electric regulations the 
“proliferation of standards committees ironically began to undermine their underlying purpose of 
providing greater cooperation and organization.”101 This marked the second critical turning point 
in the nomenclature debate of the 1970s. The Cambridge Gene Scare revealed a sense of public 
distrust about the ability of large agencies to regulate gene splicing research. While local 
communities called for a moratorium on gene splicing research to be endorsed by major 
scientific institutions, researchers resented the multitude of national regulatory standards with 
authority over locally developed regulatory practice. Dissatisfaction in gene splicing norms in 
both the public and academic spheres later contributed to institutional reluctance to establish 
standards in the early decades of the Human Genome Project.  
 
The Frontier Re-discovered: McKusick’s Morbid Anatomy of the Genome  
  Victor McKusick was a driving force in determining the future course of the 
Human Genome Project. McKusick was considered the father of medical genetics. A cardiologist 
by training, McKusick opted to leave the well-established field of cardiology in favor of a career 
in the fledgling field of genetics, a decision his colleagues considered ill-advised. One of 
McKusick’s foremost interests was nosology, the study and classification of genetic diseases and 
malformations. McKusick acknowledged the importance of a classification system to medical 
diagnosis, treatment and genetic counseling, and raising attention in the medical community to 
the possibilities of collaboration between medicine and genetics.  
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In 1973, McKusick collaborated with his fellow Johns Hopkins colleague Frank Ruddle 
to plan the first Human Gene Mapping (HGM) workshop. The workshop aimed to centralize 
information sharing about the progress and potentiality of a coordinated human gene map by 
discussing recent mapping efforts. During his career at Johns Hopkins, which spanned over five 
decades, McKusick became the foremost proponent of medical genetics, a field that combined 
the academic expertise of classically-trained geneticists with the best medical knowledge and 
research available on disease pathology. McKusick referred to the result of his endeavors as the 
morbid anatomy of the human genome, that is, the study of genetic mutations and their 
relationship to human disease acquisition.102 In addition to creating the Mendelian Inheritance in 
Man, an online catalog of known linkages between regions of DNA and inheritable diseases, 
McKusick also organized international mapping meetings to discuss collaborative interest in a 
human genome mapping effort. By 1976, at least one gene had been mapped to each 
chromosome and exactly one decade later, American scientists had discovered the specific 
genetic mutation that caused Huntington’s Disease.103 As the first chair of the Division of 
Medical Genetics at Johns Hopkins, McKusick was keen in his enthusiasm regarding the field:  
As human geneticists we are privileged to work in a scientifically important field and a 
field of intellectual challenge. This is a field with particular fascination because it 
involves the most fundamental and pervasive aspects of our species. To have… the 
opportunity to contribute to human welfare and to be of service to families and 
individuals through medical genetics and clinical genetics is a privilege.104 
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McKusick’s centrality to the Project is further evidenced in his participation in a 
committee on prospective gene mapping sponsored by the National Research Council. Along 
with James Watson and Sydney Brenner, McKusick’s committee concluded that the gene 
mapping project should be initiated immediately, and completed within fifteen years of its 
commencement. McKusick encouraged shifting the course of the early human genome project to 
focus on the medical and pharmaceutical applications of gene sequencing. This offered 
pharmaceutical companies an opportunity to begin research and development projects closely 
related to the Human Genome Project.  
 Interest in a Human Genome Project was well-established by 1976, and the stakes were 
high. Three general categories of interest emerged from debates about the potentiality of 
mapping the human genome, and their collision created fireworks in the scientific, political, and 
corporate spheres. These three categories were: private interest in developing profitable 
biomedical applications; academic interests in continued scientific research; and the public 
interest in ethical and moral implications of human gene mapping. By 1976, the debate over 
genetically-modified insulin created tensions in each sphere surrounding intellectual property 
and ownership. These tensions created an intellectual property conundrum related to genome 
nomenclature, and set legal standard for the future course of the Human Genome Project.  
  
Private Interest: A Brief History of Eli Lilly and Co.  
 
 Although new to the Human Genome Project in the 1970s, pharmaceutical giant Eli Lilly 
and Company held a long-standing interest in the creation and distribution of human insulin. In 




would allow him to isolate and extract natural portions of the human pancreas that produce 
insulin. By January of 1922, the first patient at the Toronto General Hospital had proven 
Banting’s success: the patient had awakened from a comatose state with the injection of 
insulin.105 By November of that same year, Eli Lilly and Co. had refined the extraction and 
purification process, and it was the first major pharmaceutical company to offer insulin on the 
market.  
 Fifty years later marked a renewed scientific interest in human insulin development, and 
Eli Lilly and Co. was determined to remain at the forefront of its re-emergence. In 1976, private 
interest in the Human Genome Project gained a significant foothold, when Herbert Boyer left his 
position as assistant professor of biochemistry at the University of California to found 
Genentech. Boyer modeled Genentech as the first genetic engineering company in the United 
States. The first major research initiative sponsored by Genentech was a method to genetically 
engineer synthetic human insulin. Prior to 1976, the insulin produced by Eli Lilly and Co. relied 
upon extractions from mammals, most often canines. Genetically engineered insulin from human 
beings held a number of benefits. Primarily, it was more cost effective to produce than insulin 
derived from canines. Moreover, synthetic insulin led to fewer allergenic reactions among human 
users than the insulin produced from canines. Within two years of its establishment, Genetench 
had collaborated with scientists at the Beckmann Research Institute to produce synthetic human 
insulin. Meanwhile, as the Lilly Company prepared to market Humulin, the pharmaceutical 
brand name for synthetic insulin, researchers at the University of California had developed a new 
mechanism for sequencing and cloning human insulin.  
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Academic Sphere: The University of California  
In 1977, Australian born biochemist John Shine was completing a postdoctoral 
fellowship in the departments of Biochemistry and Biophysics at the University of California, 
San Francisco.106 His research had led him to develop a Recombinant DNA (cloning) technique 
(known as a ligase catalyzed reaction), a crucial step in the human insulin replication process.  
On May 27, 1977 Shine and a group of colleagues at the University of California filed a patent 
application for the process the research team had developed.107 In September, Shine filed a 
second related patent application related to the purification of a protein sequence, specifically the 
sequence associated with insulin production.108 Both patents were on behalf of the Regents Of 
The University of California. By April 1978, Shine had filed yet another patent, this time related 
to the recombinant (cloning) bacterial plasmids that coded specifically for insulin genes. The 
research for this patent had been funded by a grant from the California Department of Health, 
Education, and Welfare.109 Specifically, this patent claimed the recombinant DNA process, “to 
contain a nucleotide sequence having the structure of the reverse transcript of an mRNA of a 
vertebrate, which mRNA encodes insulin.”110 The application included a claim over vertebrates 
having the nucleotide sequence and structure of transcribed insulin from the rat gene for insulin. 
The application also included two claims that the method for coding synthetic insulin was 
applicable to a microorganism where the vertebrate was a mammal, and a microorganism where 
the vertebrate was a human. Thus, the patent application included mammals, microorganisms, 
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and humans in its periphery. As the patent description states, Shine and his colleagues were 
interested in the right to, “present [an] invention related to the isolation of the insulin gene, its 
purification, transfer, and replication in a microbial host and its subsequent characterization.”111                  
The work on recombinant DNA conducted at the University of California was unprecedented; 
indeed it was “the first time the entire genetic sequence for an insulin gene had been spelled 
out.”112 While the University of California moved forward with its method patents for the 
extraction, isolation, and purification of insulin, testing primarily on rodents to study whole 
system outcomes of the research, Lilly scientists prepared to test a new form of synthetic insulin 
extracted from portions of human bacterial growth.  
 
A Civil Attempt 
By 1977, the University of California Regents had agreed to license the recombinant 
DNA patents for human insulin to Genentech, the first California-based genetic engineering 
start-up. Lilly was headquartered in Indianapolis and Genentech was based in San Francisco, but 
both companies were well aware of one another’s research endeavors in creating a synthetic 
insulin product. On August 25, 1978 Eli Lilly and Co. and Genentech Inc. entered into a contract 
regarding their respective research on synthetic insulin. The agreement stated that Genentech had 
established a scientifically valid method for the extraction, purification, and synthetic re-creation 
of human insulin, and that Genentech held license to the related patent rights filed by John Shine 
and his research colleagues at the University of California. As was later described, “the Insulin 
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Agreement gave Lilly access to Genentech biological material which Lilly in turn was to use in 
developing and marketing synthetically produced human insulin.”113 Under Article VI of the 
Insulin Agreement, Genentech agreed to allow Lilly the exclusive patent, “to use its biological 
material for the limited purpose of manufacturing, selling, and using Recombinant insulin 
without regard to Genentech patent rights.”114 Lilly agreed to disburse royalties to Genentech, 
and proceeded to production.  
From 1977-1980 Eli Lilly and Co. had invested over sixty million dollars on 
manufacturing facilities that were equipped to produce and distribute Humulin on a rapid and 
systematic scale.115 The company projected that once Humulin reached the market, worldwide 
pharmaceutical sales would apex at 1.1 billion dollars, and synthetic insulin was the catalyst 
intended to propel the pharmaceutical industry into a new frontier.  On July 15, 1980 Eli Lilly 
authorized the first medical application of their new drug, Humulin, on a human diabetic patient 
at Guy’s Hospital in London. The patient, like other diabetics, had a known allergic reaction to 
the insulin produced from animals, and a chemical duplicate of the insulin produced from 
bacteria of the human pancreas was a strong prospective solution.  
 Exactly one decade following Lilly’s successful test of Humulin in London, legal turmoil 
erupted. In early 1990, Genentech filed suit against Eli Lilly Co. and contended that, “Lilly’s 
research and production exceeded the scope of [the] limited patent license…[and furthermore] 
used the biological material referred to in the agreement to…develop a human growth hormone 
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in order to compete with Genentech’s human growth hormone product. Genetech assert[ed] that 
such a production was beyond the scope of the license…and a breach of the parties’ contract.”116 
 
A Return to Nomenclature  
The suit became one of several filed by Genentech against Eli Lilly and Company; 
grievances included infringement of contractual terms of use, violation of patent, and the attempt 
to repurpose biological material licensed by Genentech to create an unrelated product. In each 
hearing, the legal decisions of the court hinged upon the question nomenclature. The court 
agreed with Lilly in grievances related to the contract, and noted that the University of 
California, along with Genentech, had only outlined limited terms of use in the contract with 
Lilly, and had not sufficiently described the negative covenant, that is, the terms by which the 
contract could not be used. Jude Flaum of the Federal District Court of Indiana (Southern 
District) granted Lilly patent rights outside of the contract established with Genentech, because 
the later had failed to sufficiently describe the specific parameters of use in the contract: 
 
“As a general rule covenants may only be implied into an integrated agreement when the 
implied term is not inconsistent with some express term of the contract and where there 
arises from the language of the contract itself, an inference that it is absolutely necessary 
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Perhaps the most contested episode over nomenclature occurred in 1990, when the 
University of California again brought suit against Eli Lilly and Co. for claims of infringement of 
section 525 of the patent for recombinant human insulin. The 525 patent, also known as the 
Written Description Requirement, was first applied as an amendment to the Patent Act of 
1793.118 The Written Description requirement ensured that the inventor could not extend the 
claims or benefits of the invention beyond its actual scope. It was also a standard proof to ensure 
that those seeking a patent could intelligibly explain the method for arriving at the end product. 
However, as many legal scholars have acknowledged, the significance and application of written 
description changed considerably following Regents of the University of California v. Eli Lilly 
and Company- a legal battle that ensued well into the first decade of the Human Genome Project. 
 The legal debate between the University of California and Eli Lilly and Co. revealed that 
both institutions had developed synthetic insulin based on tried and true scientific tests. The first 
tests were completed on rodents, and allowed John Shine and fellow researchers to uncover the 
exact DNA sequence that coded for insulin. The Insulin Agreement between the two parties then 
allowed Lilly to create Humulin, a product later tested on human diabetic patients. The court 
never debated whether each party had created something considerable- rather, it determined 
which institution had the legal right to patent the product. And the basis for this determination 
was 525, the Written Description agreement. Although the University of California adhered to 
the traditional expectation that the 525 written description would outline an intelligible method 
for the extraction, isolation, and purification of insulin, Lilly argued that the outcome itself (i.e. 
the actual nucleotide sequence for insulin) had not been included in the 525 section of the patent 
application. Lilly subsequently determined that description provided by the University of 
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California had outlined the method used for insulin extraction on rodents, rather than on humans. 
However, the extended nucleotide sequence between rodents and humans varied by only a single 
nucleotide on the gene that coded for insulin. As legal scholar Janice M. Mueller remarked, 
“Although UC included in the 525 patent a constructive or prophetic example describing a 
method that could be used to obtain the human insulin used to encode cDNA, as well as amino 
acids of human insulin, UC did not actually isolate and sequence cDNA until two years after the 
1977 filing date.”119 
 This left two caveats: first, that the University of California had obtained the nucleotide 
sequence for human insulin by the time the case was heard in 1997, and second that the initial 
decision heard by the District Court in San Francisco significantly changed the expectation for 
written description in patent applications to include not just a description of the method but also 
a description of the product itself. As Mueller concluded in her report, “Lilly aptly illustrate[d] 
the increased widening of the gulf between the norms of business and scientific communities and 
the U.S. patent system, as users of the later come to understand that the patent system no longer 
reflects the realities of scientific contribution.”120 Those proficient in the field of genetics were 
aware of the biological nature of the work completed at the University of California; the method 
utilized to create a synthetic form of insulin in humans was based upon (and conceptually 
identical) to the method utilized to create the synthetic insulin in rodents. Yet the University of 
California did not anticipate that the standard set by written description required, for the first 
time, a description of both the method and the product itself. One opinion issued by the decision 
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noted, “rather than awarding patent protection to the first to make it possible to clone a particular 
gene family, the written description standard of Lilly require[d] that the patent right go to the first 
firm to sequence a number of the genes (and accurately describe this sequence).  This 
firm…reap[ed] the benefits of an invention made possible by the research of others.”121 Although 
the University of California was in possession of a novel method for synthetic insulin production 
and later the nucleotide sequence for human insulin, the way researchers at UC described their 
achievements ultimately prevented a claim over ownership of intellectual property. 
 
Implications 
In the span of time required to amend the initial patent held by the University of 
California, Eli Lilly and Co. had utilized the sequence information from the Insulin Agreement to 
establish the number of human nucleotides in insulin and file a patent with a specific written 
description of their findings.122 Corporate competition had deterred academic innovation and 
Lilly was granted a twenty year premium over insulin research. In one year alone, Eli Lilly 
recorded a net profit of 1.114 billion dollars on Humulin, charging more than twice the expected 
market price for non-synthetic, animal-based insulin.123 The decision in Regents of the University 
of California v. Eli Lilly and Co. hinged on the written description requirement for patent 
applications, although the parameters of 525 were significantly altered to include description not 
only of the method to arrive at the invention, but also a highly detailed description of the novelty 
itself (thereby implying authentic discovery and inventive ownership). This case spurred debates 
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over the nature of ownership: could scientists own a specific method, or had written description 
become inclusive enough to include ownership of biological material? If the later were true, what 
mechanisms were in place to govern the ethical, legal, and social utility of biological material? 
Furthermore, if public taxpayer dollars had contributed to the research at the University of 
California, could a District Court re-appropriate the research to a private, for-profit corporation?  
 Predictions aside, Regents of the University of California v. Eli Lilly Co. indicated a 
fundamental change in scientific research and its relationship to bureaucracy. On December 12, 
1980, ten days after the University of California and Genentech were issued a patent for an early 
recombinant DNA method, the United States Bayh-Dole Act was passed. The legislation 
supported patent and license applications granted to private (biotechnology) companies that were 
the product of federally funded (often academic) research. The Bayh-Dole Act was an attempt to 
spur economic growth by allowing federally-held patents to be licensed for commercial use. The 
debate over synthetic insulin was an indicative precursor of the relations between government, 
academia, and the private sector at the outset of the Human Genome Project. Dr. Mildred Cho of 
Stanford indicated that as a result of the Bayh-Dole, “university research is [now] skewed toward 
marketable products and not basic research.”124  
 By 1979, the international community had attempted to resolve the nomenclature 
question. During the fifth international Human Gene Mapping Conference in Edinburgh, a 
committee on gene nomenclature developed a set of guidelines to ensure that gene naming was 
consistent and intelligible to the gene mapping community.  This committee was led by Dr. 
Phyllis McAlpine, who helped to create guidelines and standards for gene nomenclature in 
scientific publications and reports. McApline also introduced these standards to foster 
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collaboration and communication between the multitude of international organizations and 
laboratories working on the gene map.  
 However, just one year before the Edinburgh guidelines were issued, Eli Lilly and Co. 
had entered into contract with Genentech and the University of California in an agreement 
related to gene sequences for human insulin. The agreement marked a transformation in 
molecular nomenclature from a useful organizational tool to a critical component of the 525 
patent requirement that all biological products be described in an intelligible and systematic 
manner. In the absence of a clear nomenclature system, the University of California lost the 
opportunity to claim rights over the discovery of insulin’s genetic sequence. When the 
nomenclature question was addressed in 1979, the public and private biotechnology sectors were 
already embroiled in heated disputes over ownership rights and intellectual property. 
Furthermore, debates over nomenclature reveal how the body became a contested terrain in the 
midst of the Human Genome Project.  
 
Conclusion 
 The nomenclature question revealed a set of structural inconsistencies between the 
scientific community, the legal sphere, and the private sector. Legal scholars have suggested that 
the debates over intellectual property in the Human Genome Project transcended the structural 
legal framework in place to respond to emerging debates over biological property and ownership. 
The alteration of written description, from a method description to a comprehensive product 
description, set precedent for future cases involving genetic research and ultimately reconfigured 
the boundaries and limitations of scientific discovery at the outset of the Human Genome 
Project.   
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Although Vannevar Bush predicted an accurate trend in basic research following the end 
of the second World War, perhaps genetic advancements now trended again toward applied 
scientific research. While Bush and Schrodinger both predicted a new era of scientific discovery, 
the Human Genome Project was never preordained. Instead, the Project culminated from half a 
century of debates over the future of biological research, the transition from basic to applied 
research, advancements made in the cytogenetics community, and the pivotal role of 
nomenclature in configuring intellectual property as a central component of genetic research. 
The Human Genome Project engaged not only the scientific community, but the academic and 
research world at-large, the medical community, the corporate sphere, as well as legislators, 
ethicists, and the interested public. Debates about the Human Genome Project emerged and re-
evolved over the course of fifty years because the implications were both extensive and 
profound.  
Tracing the intellectual development of the Human Genome Project confirms that the 
modern body cannot hold the same spatial and ontological existences as the body of yesterday. 
Cultural and intellectual discourses and past processes of transformation inevitably shape bodies. 
The Human Genome Project emerged as one of the most critical catalysts for understanding the 
human body in the twentieth century. The Project is the embodiment of an era, marked by 
bioethical scholarship, concerns of legal patentability, technological and scientific advances in 
molecular biology and computational software, and institutional encounters between public and 
private spheres. Although the Human Genome Project yielded ethical, legal, social, 
technological, and scientific implications (many yet to be revealed) the human body remained 
the fulcrum of human genomic possibility. Indeed, it was from the Human Genome Project, its 
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integration into systems of knowledge and power125 and its theoretical and tangible nature, that a 
new narrative of self-hood emerged, which simultaneously expanded the known territory of the 
body and constrained its spatiality through definitions, standards, and categories of language in 
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